4-76035118-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005409.5(CXCL11):āc.190A>Gā(p.Ile64Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,588,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005409.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000314 AC: 4AN: 127360Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250908Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135636
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461558Hom.: 0 Cov.: 35 AF XY: 0.0000138 AC XY: 10AN XY: 727078
GnomAD4 genome AF: 0.0000314 AC: 4AN: 127360Hom.: 0 Cov.: 34 AF XY: 0.0000326 AC XY: 2AN XY: 61400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.190A>G (p.I64V) alteration is located in exon 3 (coding exon 3) of the CXCL11 gene. This alteration results from a A to G substitution at nucleotide position 190, causing the isoleucine (I) at amino acid position 64 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at